Decreased protein Z concentrations complicating the hypercoagulable state of Behçet's disease

Clinical and Applied Thrombosis/Hemostasis

Volumn 9, Issue 3, 2003, Pages 259-263

  Öztürk, Mehmet Akif ^a,b   Özbalkan, Zeynep ^a   Onat, A Mesut ^a   Ertenli, Ihsan ^a   Kiraz, Sedat ^a   Aytemir, Kudret ^a   Üreten, Kemal ^a   Abali, Gülcan ^a   Çalgüneri, Meral ^a   Kirazli, Şerafettin ^a   Haznedaroglu, Ibrahim C ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Beh et's disease; Protein Z; Prothrombotic state

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; FATTY ACID BINDING PROTEIN;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; LIVER DYSFUNCTION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; VASCULAR DISEASE;

EID: 0041328246     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960300900312     Document Type: Article

References (32)

1. Sakane T, Takeno M, Suzuki N, et al. Behqet's disease. N Engl J Med 1999;341:1284.
2. Haznedaroglu IC, Çelik I, Büyükaşik Y, et al. Haemostasis, thrombosis, and endothelium in Behçet's disease. Acta Haematol 1998;99:296.
3. Hampton KK, Chamberlain MA, Menon DK, et al. Coagulation and fibrinolytic activity in Behçet's disease. Thromb Haemost 1991;66:292.
4. Guermazi S, Hamza M, Dellagi K. Protein S deficiency and antibodies to protein S in patients with Behcet's disease. Thromb Res 1997;86:197.
5. Mader R, Ziv M, Adawi M, et al. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease. J Rheumatol 1999;26:2404.
6. Haznedaroglu IC, Ozcebe O, Çelik I, et al. Haemostatic markers of procoagulant inbalance in Behçet's disease. Eur J Haematol 1996;57:107.
7. Gül A, Ozbek U, Ozturk C, et al. Coagulation factor V gene mutation increases the risk of venous thrombosis in Behcet's disease. Br J Rheumatol 1996;35:1178.
8. Lesprit P, Wechsler B, Piette JC, et al. Activated protein C resistance caused by factor V Arg506Gln mutation has no role in thrombotic manifestations of Behçet's disease. Ann Rheum Dis 1995;54:860.
9. Toydemir PB, Elhan AH, Tükün A, et al. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothrombin gene G20210A mutations on deep venous thrombosis in Behçet's disease. J Rheumatol 2000;27:2849.
10. Kosar A, Haznedaroglu IC, Büyükaşik Y, et al,. Activated protein C resistance in Behçet's disease. Rheumatol Int 1998;17:249.
11. Gül A, Aslantas AB, Tekinay T, et al. Procoagulant mutations and venous thrombosis in Behçet's disease. Rheumatology 1999;38:1298.
12. Kosar A, Ozturk M, Haznedaroglu IC, et al. Hemostatic parameters in Behcet's disease: A reappraisal. Rheumatol Int 2002;22:9.
13. Broze GJ Jr. Protein Z-dependent regulation of coagulation. Thromb Haemost 2001;86:8.
14. Usalan C, Erdem Y, Altun B, et al. Protein Z levels in haemodialysis patients. Int Urol Nephrol 1999;31:541.
15. Heeb MJ, Paganini-Hill A, Griffin JH, et al. Low protein Z levels and risk of ischemic stroke: Differences by diabetic status and gender. Blood Cells Mol Dis 2002;29:139.
16. Kobelt K, Biasiutti FD, Mattle HP, et al. Protein Z in ischaemic stroke. Br J Haematol 2001;114:169.
17. Vasse M, Guegan-Massardier E, Borg JY, et al. Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet 2001;357:933.
18. McColl MD, Deans A, Maclean P, et al. Plasma protein Z deficiency is common in women with antiphospholipid antibodies. Br J Haematol 2003;120:907.
19. Steffano B, Forastiero R, Martinuzzo M, et al. Low plasma protein Z levels in patients with antiphospholipid antibodies. Blood Coagul Fibrinolysis 2001;12:411.
20. Kiraz S, Ertenli I, Öztürk MA, et al. Pathological haemostasis and 'prothrombotic state' in Behçet's disease. Thromb Res 2002;105:125.
21. Miletich JP, Broze GJ Jr. Human plasma protein Z antigen: Range in normal subjects and effect of warfarin therapy. Blood 1987;69:1580.
22. Kemkes-Matthes B, Matthes KJ. Protein Z deficiency: A new cause of bleeding tendency. Thromb Res 1995;79:49.
23. Ravi S, Mauron T, Lammle B, et al. Protein Z in healthy human individuals and in patients with a bleeding tendency. Br J Haematol 1998;102:1219.
24. Gamba G, Bertolino G, Montani N, et al. Bleeding tendency of unknown origin and protein Z levels. Thromb Res 1998;90:291.
25. Yin ZF, Huang ZF, Cui J, et al. Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci USA 2000;97:6734.
26. Lopaciuk S, Bykowska K, Kwiecinski H, et al. Protein Z in young survivors of ischemic stroke. Thromb Haemost 2002;88:536.
27. Kemkes-Matthes B, Nees M, Kühnel G, et al. Protein Z influences the prothrombotic phenotype in factor V Leiden patients. Thromb Res 2002;106:183.
28. Haznedaroglu IC, Özcebe O, Özdemir O, et al. Impaired haemostatic kinetics and endothelial function in Behçet's disease. J Intern Med 1996;240:181.
29. Gül A. Behcet's disease: An update on the pathogenesis. Clin Exp Rheumatol 2001;19(suppl. 24):S6.
30. Malyszko J, Malyszko JS, Mysliwiec M. Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndrome. Blood Coagul Fibrinolysis 2002;13:615.
31. Cobankara V, Ozath D, Haznedaroglu IC, et al. Circulating protein-Z in reactive versus primary thrombocytosis and ITP. Nagoya Med J 1999;43:65.
32. Yazici H, Yurdakul S, Hamuryudan V. Behçet's syndrome. In: Klippel JH, Dieppe PA, eds. Rheumatology. London: Mosby International, 1998:7.26.1.